Evidence map›Paper›PMID 31831916›Full record

ArticleTrends in analytical chemistry : TRAC2019

Mapping human N-linked glycoproteins and glycosylation sites using mass spectrometry.

Liuyi Dang, Li Jia, Yuan Zhi, Pengfei Li, Ting Zhao, Bojing Zhu, Rongxia Lan, Yingwei Hu, Hui Zhang, Shisheng Sun

Abstract read
In one paragraph

Article in Trends in analytical chemistry : TRAC, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Mass spectrometry-based structure-specificActa biochimica et biophysica Sinica · 2024
    Review
  5. Plasma/Serum Proteomics based on Mass Spectrometry.Protein and peptide letters · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The glycosylation in SARS-CoV-2 and its receptor ACE2.Signal transduction and targeted therapy · 2021
    Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Liuyi DangCollege of Life Sciences, Northwest University, Xi'an, Shaanxi province 710069, China.
Li JiaCollege of Life Sciences, Northwest University, Xi'an, Shaanxi province 710069, China.
Yuan ZhiCollege of Life Sciences, Northwest University, Xi'an, Shaanxi province 710069, China.
Pengfei LiCollege of Life Sciences, Northwest University, Xi'an, Shaanxi province 710069, China.
Ting ZhaoCollege of Life Sciences, Northwest University, Xi'an, Shaanxi province 710069, China.
Bojing ZhuCollege of Life Sciences, Northwest University, Xi'an, Shaanxi province 710069, China.
Rongxia LanCollege of Life Sciences, Northwest University, Xi'an, Shaanxi province 710069, China.
Yingwei HuDepartment of Pathology, Johns Hopkins University, Baltimore, Maryland 21287, USA.
Hui ZhangDepartment of Pathology, Johns Hopkins University, Baltimore, Maryland 21287, USA.
Shisheng SunCollege of Life Sciences, Northwest University, Xi'an, Shaanxi province 710069, China.

Funding

Shared Resource CoresP01HL107153 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ZHANG, HUI · 2011 to 2017
$16.8M
Glycoprotein biomarkers for the early detection of aggressive prostate cancerU01CA152813 · NCI · JOHNS HOPKINS UNIVERSITY · PI ZHANG, HUI · 2010 to 2021
$6.2M
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic TargetsU24CA210985 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2016 to 2020
$5.3M
Targeting Latently Infected Primary Cells using Integrated GlycoproteomicsR21AI122382 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ZHANG, HUI · 2016 to 2017
$446k
NCI NIH HHS U01 CA152813NCI NIH HHS U24 CA210985NHLBI NIH HHS P01 HL107153NIAID NIH HHS R21 AI122382
6 · The paper itself

Abstract

N-linked glycoprotein is a highly interesting class of proteins for clinical and biological research. Over the last decade, large-scale profiling of N-linked glycoproteins and glycosylation sites from biological and clinical samples has been achieved through mass spectrometry-based glycoproteomic approaches. In this paper, we reviewed the human glycoproteomic profiles that have been reported in more than 80 individual studies, and mainly focused on the

Indexed as

glycoproteinglycoproteomeGlycosylationglycosylation sitehuman body fluidshuman cell lineshuman tissuesmass spectrometry

Identifiers

PMID31831916
PMCPMC6907083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.